Characterization of the hepatic cellular uptake of α 1-acid glycoprotein (AGP), part 1

A peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells

Koji Nishi, Hisakazu Komori, Mari Kikuchi, Nao Uehara, Naoko Fukunaga, Kazuaki Matsumoto, Hiroshi Watanabe, Keisuke Nakajou, Shogo Misumi, Ayaka Suenaga, Toru Maruyama, Masaki Otagiri

Research output: Contribution to journalArticle

Abstract

Human α 1-acid glycoprotein (AGP), a serum glycoprotein, is known to have anti-inflammatory activity. We recently reported that AGP was mainly incorporated into the liver in mice via a receptor-mediated pathway, although the mechanism for this was largely unknown. The objective of this study was to identify the specific cellular surface protein that recognizes the peptide moiety of AGP. Pharmacokinetic studies of 111In-AGP and 111In -recombinant glycan-deficient AGP (rAGP) in mice demonstrated that both AGPs are mainly distributed to the liver and kidney, but hepatic and renal uptake clearance of rAGP was higher than that for AGP. Hepatic uptake of rAGP was inhibited in the presence of 100-fold excess of unlabeled AGP, indicating that the hepatic uptake of rAGP shared a common route with that of AGP and that it recognized the peptide moiety of AGPs. In ligand blotting analyses using crude cellular membrane fraction of mice liver, a band corresponding to a 16 kDa protein was observed to bind to both AGPs. Interestingly, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry MALDI-TOF-MS and western blotting analyses indicated that this 16 kDa protein is the hemoglobin β-chain (HBB). It, therefore, appears that HBB is associated with the hepatic uptake of AGP via a direct interaction with its peptide moiety.

Original languageEnglish
Pages (from-to)1599-1606
Number of pages8
JournalJournal of Pharmaceutical Sciences
Volume101
Issue number4
DOIs
Publication statusPublished - 2012 Apr
Externally publishedYes

Fingerprint

Glycoproteins
Hemoglobins
Peptides
Acids
Liver
Polysaccharides
Kidney
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Mass Spectrometry
Membrane Proteins
Proteins
Lasers
Anti-Inflammatory Agents
Pharmacokinetics
Western Blotting
Ligands
Membranes
Serum

Keywords

  • Alpha 1-acid glycoprotein
  • Distribution
  • Glycoproteins/glycoprotein receptors
  • Hepatic transport
  • Kinetics
  • Protein binding

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Characterization of the hepatic cellular uptake of α 1-acid glycoprotein (AGP), part 1 : A peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells. / Nishi, Koji; Komori, Hisakazu; Kikuchi, Mari; Uehara, Nao; Fukunaga, Naoko; Matsumoto, Kazuaki; Watanabe, Hiroshi; Nakajou, Keisuke; Misumi, Shogo; Suenaga, Ayaka; Maruyama, Toru; Otagiri, Masaki.

In: Journal of Pharmaceutical Sciences, Vol. 101, No. 4, 04.2012, p. 1599-1606.

Research output: Contribution to journalArticle

Nishi, Koji ; Komori, Hisakazu ; Kikuchi, Mari ; Uehara, Nao ; Fukunaga, Naoko ; Matsumoto, Kazuaki ; Watanabe, Hiroshi ; Nakajou, Keisuke ; Misumi, Shogo ; Suenaga, Ayaka ; Maruyama, Toru ; Otagiri, Masaki. / Characterization of the hepatic cellular uptake of α 1-acid glycoprotein (AGP), part 1 : A peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells. In: Journal of Pharmaceutical Sciences. 2012 ; Vol. 101, No. 4. pp. 1599-1606.
@article{2c6af957803645bda8f13159176bf335,
title = "Characterization of the hepatic cellular uptake of α 1-acid glycoprotein (AGP), part 1: A peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells",
abstract = "Human α 1-acid glycoprotein (AGP), a serum glycoprotein, is known to have anti-inflammatory activity. We recently reported that AGP was mainly incorporated into the liver in mice via a receptor-mediated pathway, although the mechanism for this was largely unknown. The objective of this study was to identify the specific cellular surface protein that recognizes the peptide moiety of AGP. Pharmacokinetic studies of 111In-AGP and 111In -recombinant glycan-deficient AGP (rAGP) in mice demonstrated that both AGPs are mainly distributed to the liver and kidney, but hepatic and renal uptake clearance of rAGP was higher than that for AGP. Hepatic uptake of rAGP was inhibited in the presence of 100-fold excess of unlabeled AGP, indicating that the hepatic uptake of rAGP shared a common route with that of AGP and that it recognized the peptide moiety of AGPs. In ligand blotting analyses using crude cellular membrane fraction of mice liver, a band corresponding to a 16 kDa protein was observed to bind to both AGPs. Interestingly, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry MALDI-TOF-MS and western blotting analyses indicated that this 16 kDa protein is the hemoglobin β-chain (HBB). It, therefore, appears that HBB is associated with the hepatic uptake of AGP via a direct interaction with its peptide moiety.",
keywords = "Alpha 1-acid glycoprotein, Distribution, Glycoproteins/glycoprotein receptors, Hepatic transport, Kinetics, Protein binding",
author = "Koji Nishi and Hisakazu Komori and Mari Kikuchi and Nao Uehara and Naoko Fukunaga and Kazuaki Matsumoto and Hiroshi Watanabe and Keisuke Nakajou and Shogo Misumi and Ayaka Suenaga and Toru Maruyama and Masaki Otagiri",
year = "2012",
month = "4",
doi = "10.1002/jps.22804",
language = "English",
volume = "101",
pages = "1599--1606",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Characterization of the hepatic cellular uptake of α 1-acid glycoprotein (AGP), part 1

T2 - A peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells

AU - Nishi, Koji

AU - Komori, Hisakazu

AU - Kikuchi, Mari

AU - Uehara, Nao

AU - Fukunaga, Naoko

AU - Matsumoto, Kazuaki

AU - Watanabe, Hiroshi

AU - Nakajou, Keisuke

AU - Misumi, Shogo

AU - Suenaga, Ayaka

AU - Maruyama, Toru

AU - Otagiri, Masaki

PY - 2012/4

Y1 - 2012/4

N2 - Human α 1-acid glycoprotein (AGP), a serum glycoprotein, is known to have anti-inflammatory activity. We recently reported that AGP was mainly incorporated into the liver in mice via a receptor-mediated pathway, although the mechanism for this was largely unknown. The objective of this study was to identify the specific cellular surface protein that recognizes the peptide moiety of AGP. Pharmacokinetic studies of 111In-AGP and 111In -recombinant glycan-deficient AGP (rAGP) in mice demonstrated that both AGPs are mainly distributed to the liver and kidney, but hepatic and renal uptake clearance of rAGP was higher than that for AGP. Hepatic uptake of rAGP was inhibited in the presence of 100-fold excess of unlabeled AGP, indicating that the hepatic uptake of rAGP shared a common route with that of AGP and that it recognized the peptide moiety of AGPs. In ligand blotting analyses using crude cellular membrane fraction of mice liver, a band corresponding to a 16 kDa protein was observed to bind to both AGPs. Interestingly, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry MALDI-TOF-MS and western blotting analyses indicated that this 16 kDa protein is the hemoglobin β-chain (HBB). It, therefore, appears that HBB is associated with the hepatic uptake of AGP via a direct interaction with its peptide moiety.

AB - Human α 1-acid glycoprotein (AGP), a serum glycoprotein, is known to have anti-inflammatory activity. We recently reported that AGP was mainly incorporated into the liver in mice via a receptor-mediated pathway, although the mechanism for this was largely unknown. The objective of this study was to identify the specific cellular surface protein that recognizes the peptide moiety of AGP. Pharmacokinetic studies of 111In-AGP and 111In -recombinant glycan-deficient AGP (rAGP) in mice demonstrated that both AGPs are mainly distributed to the liver and kidney, but hepatic and renal uptake clearance of rAGP was higher than that for AGP. Hepatic uptake of rAGP was inhibited in the presence of 100-fold excess of unlabeled AGP, indicating that the hepatic uptake of rAGP shared a common route with that of AGP and that it recognized the peptide moiety of AGPs. In ligand blotting analyses using crude cellular membrane fraction of mice liver, a band corresponding to a 16 kDa protein was observed to bind to both AGPs. Interestingly, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry MALDI-TOF-MS and western blotting analyses indicated that this 16 kDa protein is the hemoglobin β-chain (HBB). It, therefore, appears that HBB is associated with the hepatic uptake of AGP via a direct interaction with its peptide moiety.

KW - Alpha 1-acid glycoprotein

KW - Distribution

KW - Glycoproteins/glycoprotein receptors

KW - Hepatic transport

KW - Kinetics

KW - Protein binding

UR - http://www.scopus.com/inward/record.url?scp=84857507447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857507447&partnerID=8YFLogxK

U2 - 10.1002/jps.22804

DO - 10.1002/jps.22804

M3 - Article

VL - 101

SP - 1599

EP - 1606

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 4

ER -